FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308394985> ?p ?o ?g. }

• W4308394985 abstract "<h3>Background</h3> Single cell transcriptomics has led to the generation of large-scale atlases to understand cellular heterogeneity across both healthy and diseased tissues at the highest resolution. Such atlases have allowed for in silico inferences of fibroblast ontogeny and function, but without in vivo substantiation are limited in their utility to inspire novel fibroblast-directed therapies to improve disease outcome. In cancer, single cell studies identified the emergence of a myofibroblast population, in both mice and humans, uniquely marked by a highly restricted leucine rich repeat containing protein, LRRC15. This cancer-associated myofibroblast population expresses a multitude of extracellular matrix (ECM) associated and immunosuppressive genes. Clinically, high expression of an LRRC15⁺ CAF gene signature in bulk RNAseq data from cancer patients correlated with lack of response to anti-programmed death ligand-1 (aPDL1) checkpoint blockade therapy. It remains unclear if LRRC15⁺ CAFs are the cause of this lack of response, or if they represent a read-out of tumor-intrinsic features driving the association. Also missing are in vivo substantiation of the cellular and molecular signals driving LRRC15⁺ myofibroblast development and the direct impact LRRC15⁺ CAFs have on anti-tumor immunity. <h3>Methods</h3> To address these gaps, we paired newly developed preclinical genetic tools in murine tumor models of pancreatic cancer with a large clinical dataset of human stromal cell-sorted expression data from 159 cancer patients across 13 tumor types to understand LRRC15⁺ CAF development and function. <h3>Results</h3> In mouse models of pancreatic cancer, we provide in vivo genetic evidence that TGFβR2 signaling in healthy Dermatopontin (DPT)⁺ universal fibroblasts is essential for development of tumor-associated LRRC15⁺ myofibroblasts. Analysis of tumors from 159 patients across 13 indications revealed a conserved axis from universal fibroblasts to LRRC15⁺ myofibroblasts. This axis is the predominant driver of fibroblast lineage diversity in human cancers. Using newly developed Lrrc15-Diphtheria toxin receptor knock-in mice to selectively deplete LRRC15⁺ CAFs, we show loss of this population markedly reduced total tumor fibroblast content and recalibrated the CAF composition towards universal fibroblasts. This, in turn, relieved direct suppression of tumor-infiltrating CD8⁺ T cells to enhance their effector function and significantly augmented tumor regression in response to anti-PDL1 immune checkpoint blockade. <h3>Conclusions</h3> Collectively, these findings demonstrate that TGFβ-dependent LRRC15⁺ CAFs dictate the tumor-fibroblast setpoint to promote tumor growth, directly suppress CD8⁺ T cell functionality, and limit responsiveness to checkpoint blockade. Development of treatments that restore the homeostatic fibroblast setpoint by diminishing pro-disease LRRC15⁺ myofibroblasts may improve patient survival and response to immunotherapy." @default.
• W4308394985 created "2022-11-11" @default.
• W4308394985 creator A5011465411 @default.
• W4308394985 creator A5016009655 @default.
• W4308394985 creator A5026407317 @default.
• W4308394985 creator A5029928578 @default.
• W4308394985 creator A5031757292 @default.
• W4308394985 creator A5055187243 @default.
• W4308394985 creator A5079291119 @default.
• W4308394985 creator A5083002237 @default.
• W4308394985 date "2022-11-01" @default.
• W4308394985 modified "2023-09-25" @default.
• W4308394985 title "1450 TGFβ dependent LRRC15⁺myofibroblasts dictate the tumor fibroblast setpoint to promote cancer immunotherapy resistance" @default.
• W4308394985 doi "https://doi.org/10.1136/jitc-2022-sitc2022.1450" @default.
• W4308394985 hasPublicationYear "2022" @default.
• W4308394985 type Work @default.
• W4308394985 citedByCount "0" @default.
• W4308394985 crossrefType "proceedings-article" @default.
• W4308394985 hasAuthorship W4308394985A5011465411 @default.
• W4308394985 hasAuthorship W4308394985A5016009655 @default.
• W4308394985 hasAuthorship W4308394985A5026407317 @default.
• W4308394985 hasAuthorship W4308394985A5029928578 @default.
• W4308394985 hasAuthorship W4308394985A5031757292 @default.
• W4308394985 hasAuthorship W4308394985A5055187243 @default.
• W4308394985 hasAuthorship W4308394985A5079291119 @default.
• W4308394985 hasAuthorship W4308394985A5083002237 @default.
• W4308394985 hasBestOaLocation W43083949851 @default.
• W4308394985 hasConcept C104317684 @default.
• W4308394985 hasConcept C121608353 @default.
• W4308394985 hasConcept C142724271 @default.
• W4308394985 hasConcept C150194340 @default.
• W4308394985 hasConcept C16930146 @default.
• W4308394985 hasConcept C207865475 @default.
• W4308394985 hasConcept C2776107976 @default.
• W4308394985 hasConcept C2779733811 @default.
• W4308394985 hasConcept C2780381497 @default.
• W4308394985 hasConcept C2780559512 @default.
• W4308394985 hasConcept C2908647359 @default.
• W4308394985 hasConcept C2909706936 @default.
• W4308394985 hasConcept C502942594 @default.
• W4308394985 hasConcept C54355233 @default.
• W4308394985 hasConcept C71924100 @default.
• W4308394985 hasConcept C81885089 @default.
• W4308394985 hasConcept C86803240 @default.
• W4308394985 hasConcept C96232424 @default.
• W4308394985 hasConcept C99454951 @default.
• W4308394985 hasConceptScore W4308394985C104317684 @default.
• W4308394985 hasConceptScore W4308394985C121608353 @default.
• W4308394985 hasConceptScore W4308394985C142724271 @default.
• W4308394985 hasConceptScore W4308394985C150194340 @default.
• W4308394985 hasConceptScore W4308394985C16930146 @default.
• W4308394985 hasConceptScore W4308394985C207865475 @default.
• W4308394985 hasConceptScore W4308394985C2776107976 @default.
• W4308394985 hasConceptScore W4308394985C2779733811 @default.
• W4308394985 hasConceptScore W4308394985C2780381497 @default.
• W4308394985 hasConceptScore W4308394985C2780559512 @default.
• W4308394985 hasConceptScore W4308394985C2908647359 @default.
• W4308394985 hasConceptScore W4308394985C2909706936 @default.
• W4308394985 hasConceptScore W4308394985C502942594 @default.
• W4308394985 hasConceptScore W4308394985C54355233 @default.
• W4308394985 hasConceptScore W4308394985C71924100 @default.
• W4308394985 hasConceptScore W4308394985C81885089 @default.
• W4308394985 hasConceptScore W4308394985C86803240 @default.
• W4308394985 hasConceptScore W4308394985C96232424 @default.
• W4308394985 hasConceptScore W4308394985C99454951 @default.
• W4308394985 hasLocation W43083949851 @default.
• W4308394985 hasOpenAccess W4308394985 @default.
• W4308394985 hasPrimaryLocation W43083949851 @default.
• W4308394985 hasRelatedWork W1153537512 @default.
• W4308394985 hasRelatedWork W2740526889 @default.
• W4308394985 hasRelatedWork W2809831584 @default.
• W4308394985 hasRelatedWork W2917766674 @default.
• W4308394985 hasRelatedWork W3080204357 @default.
• W4308394985 hasRelatedWork W3163457197 @default.
• W4308394985 hasRelatedWork W4205918578 @default.
• W4308394985 hasRelatedWork W4231860814 @default.
• W4308394985 hasRelatedWork W4248193217 @default.
• W4308394985 hasRelatedWork W4284965464 @default.
• W4308394985 isParatext "false" @default.
• W4308394985 isRetracted "false" @default.
• W4308394985 workType "article" @default.